Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2004
07/29/2004WO2004063192A1 Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
07/29/2004WO2004063186A1 Thiophene-carboxamide derivatives and their use as inhibitors of the enzime ikk-2
07/29/2004WO2004063185A1 Thiophene carboxamides as inhibitors of the enzyme ikk-2
07/29/2004WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004WO2004063157A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments
07/29/2004WO2004062562A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004WO2004050024A3 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/29/2004WO2004033422A3 Modulation of anxiety through blockade of anandamide hydrolysis
07/29/2004WO2004031401A3 Novel tyrosine kinases inhibitors
07/29/2004WO2004018419B1 Benzimidazole quinolinones and uses thereof
07/29/2004WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
07/29/2004US20040147751 Crystalline form of (3R,4R)-4-[3-(S)-Hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
07/29/2004US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide
07/29/2004US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders
07/29/2004US20040147745 Novel compounds and compositions as protease inhibitors
07/29/2004US20040147744 2-(N-cyano-N-methylamino)-4-chloro-5-(2,4,6-trifluorophenyl)-6-(1,1,1-trifluoroprop-2-ylamino)-pyrimidine; synthesis; treating plant locus
07/29/2004US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis
07/29/2004US20040147593 Eating disorders; sleep disorders; obesity
07/29/2004US20040147576 Cardiovascular disorders; thrombosis; anticoagulants
07/29/2004US20040147573 Metalloproteinase inhibitors
07/29/2004US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/29/2004US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders
07/29/2004US20040147554 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxy-quinolin-4-yl)propyl]-1-[2-2thienylthio)ethyl] piperidine-3-carboxylic acid
07/29/2004US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases
07/29/2004US20040147535 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease ; leukemia; antiarthritic agents
07/29/2004US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
07/29/2004US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists
07/29/2004US20040147518 4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]-1-[2-(thien-2-yl)thioethyl]piperidine-4-carboxylic acid or salt for example; antibacterial activity
07/29/2004US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/29/2004US20040147507 Compositions useful as inhibitors of JAK and other protein kinases
07/29/2004US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome
07/29/2004US20040147502 Beta lactam compounds and their use as inhibitors of tryptase
07/29/2004US20040147454 Aspartyl protease inhibitors
07/29/2004US20040147429 Endogenous, constitutively activated G protein-coupled orphan receptors
07/29/2004US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation
07/29/2004US20040146542 Non-therapeutical process for deterring vermin from warm-blooded animals, whereby 2-substituted-piperidine compound is is applied topically, together with a spreading additive, to the skin, the pelt or the plumage of the warm-blooded animal
07/29/2004US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
07/29/2004DE10301519A1 New substituted 9-keto-spinosyn derivatives, useful for control of animal pests and microorganisms, in plant protection and veterinary medicine, also new intermediates
07/29/2004CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004CA2512813A1 Use of substituted 2-phenylbenzimidazoles as phamaceutical compositions
07/29/2004CA2512336A1 Thiophene carboxamides as inhibitors of the enzyme ikk-2
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004CA2510400A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004CA2510382A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/28/2004EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
07/28/2004EP1440972A1 Novel benzothiepines having pharmaceutical activity.
07/28/2004EP1440070A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
07/28/2004EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
07/28/2004EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
07/28/2004EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/28/2004CN1516698A Arylindenopyridines with PDE inhibiting activity
07/28/2004CN1516697A Aromatic dicarboxylic acid derivatives
07/28/2004CN1516691A Phenylpyridine carbonyl piperazine derivative
07/28/2004CN1516690A Heterocyclic derivatives and medicines
07/28/2004CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/28/2004CN1516580A Sulfonamides
07/28/2004CN1515569A Indole and 2,3-indoline derivative, their preparation and application
07/28/2004CN1515568A Indole and 2,3-indoline derivative, their preparation and application
07/28/2004CN1515567A New benzothiaheptylyin with ileal bile acid transfer and taurocholate absorption inhibitor activity
07/28/2004CN1515566A Substituted chromene derivative for curing inflammation
07/28/2004CN1515550A Thrombosis resisting preparation
07/28/2004CN1159302C Triazine derivatives, their production and use
07/28/2004CN1159298C Parasiticidal compound
07/28/2004CN1159295C Inhibitors of metalloproteinases
07/28/2004CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands
07/27/2004US6767919 High specificity anticancer agents
07/27/2004US6767916 Chalcone coumarins
07/27/2004US6767915 Substituted piperidines as melanocortin receptor agonists
07/27/2004US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
07/27/2004US6767907 For therapy of psychic and neurologic disorders
07/22/2004WO2004060886A1 (3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli [-1-'2-(2-thienylthio) ethyl ]ipiperidine-3-carboxylic acid crystalline form
07/22/2004WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
07/22/2004WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004WO2004060872A1 Factor xa inhibitors
07/22/2004WO2004060870A1 Novel cb 1 receptour inverse agonists
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004WO2004043368A3 Sulfonamides
07/22/2004WO2004024086A3 Compounds, compositions and methods
07/22/2004WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same
07/22/2004WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors
07/22/2004WO2002096886A8 Pyrimidine derivatives
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
07/22/2004US20040142997 Alzheimer's disease
07/22/2004US20040142996 Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation
07/22/2004US20040142981 Sterilization, antiseptics for bacteria infections
07/22/2004US20040142980 Viricides; hepatitis virus infections
07/22/2004US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis
07/22/2004US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/22/2004US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease
07/22/2004US20040142971 Benzothiophene compounds having antiinfective activity
07/22/2004US20040142967 Pain maintenance
07/22/2004US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142964 Novel compounds
07/22/2004US20040142963 Cardiovascular disorders